The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide and semaglutide are the only two GLP-1 drugs FDA-approved to treat obesity in kids ages 12 and up.

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether you have type 2 diabetes or obesity, you may have heard about medications like Ozempic® that can help manage blood sugar levels and weight.

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an endocrinologist at Northwell Lenox Hill Hospital, told The Post.

The U.S. Food and Drug Administration has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a higher risk of inhaling gastric contents

Dr. Danish Ali discusses the dangers associated with alternate versions of a popular weight loss drug. Deion Sanders imposed harsh punishment on Colorado players after they disregarded his game plan A Man Went on a Hike—and Found a Mysterious Cart Buried Under Ice for Decades US Navy destroyers unscathed after fighting off a complex attack of cruise and ballistic missiles and exploding drones How ‘Yellowstone’ Honored a Cowboy Legend Trump taps Elon Musk and Vivek Ramaswamy to lead Department of Government Efficiency The Brands Behind 19 Popular Kirkland Products At Costco The unhealthiest fast-food sandwich in America isn't a Big Mac,